Lisa F Lincz

Summary

Affiliation: University of Newcastle
Country: Australia

Publications

  1. doi request reprint Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Calvary Mater Newcastle Hospital, NSW, Australia
    Thromb Res 129:192-6. 2012
  2. ncbi request reprint Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, Australia
    Pathophysiol Haemost Thromb 35:435-9. 2006
  3. doi request reprint Thrombin generation as a predictor of radiotherapy induced skin erythema
    Lisa F Lincz
    Department of Haematology, Calvary Mater Newcastle, NSW, Australia
    Radiother Oncol 90:136-40. 2009
  4. pmc Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant
    Lisa F Lincz
    Department of Haematology, Calvary Mater Newcastle, Newcastle, NSW, Australia
    Neoplasia 10:1131-7. 2008
  5. ncbi request reprint Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Misericordiae Hospital, Waratah, Australia
    Blood Coagul Fibrinolysis 18:559-64. 2007
  6. doi request reprint Circulating microparticles are elevated in carriers of factor V Leiden
    Anoop K Enjeti
    Hunter Haematology Research Group, Calvary Mater Newcastle, Edith Street, Waratah, NSW 2298, Australia
    Thromb Res 126:250-3. 2010
  7. ncbi request reprint Genetic variations in benzene metabolism and susceptibility to multiple myeloma
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Edith Street, Waratah, NSW 2298, Australia
    Leuk Res 31:759-63. 2007
  8. ncbi request reprint Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma
    Gough G Au
    The Picornaviral Research Unit, School of Biomedical Sciences, Faculty of Health, The University of Newcastle, Newcastle, NSW, Australia
    Br J Haematol 137:133-41. 2007
  9. ncbi request reprint Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, NSW, Australia
    Br J Haematol 120:1051-4. 2003
  10. ncbi request reprint Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, NSW 2298, Australia
    Int J Cancer 120:1930-4. 2007

Detail Information

Publications16

  1. doi request reprint Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Calvary Mater Newcastle Hospital, NSW, Australia
    Thromb Res 129:192-6. 2012
    ..Here we sought to determine if these subjects differed in their plasma levels of FVL and if this was related to MP concentrations and/or history of thrombosis...
  2. ncbi request reprint Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, Australia
    Pathophysiol Haemost Thromb 35:435-9. 2006
    ..The recent introduction of diagnostic ETP measurements in the form of the calibrated automated thrombin generation from Thrombinoscope and the TechnoThrombin from Baxter should facilitate such studies...
  3. doi request reprint Thrombin generation as a predictor of radiotherapy induced skin erythema
    Lisa F Lincz
    Department of Haematology, Calvary Mater Newcastle, NSW, Australia
    Radiother Oncol 90:136-40. 2009
    ..Based on the recent findings in patients suffering from chronic urticaria, we sought to determine if similar mechanisms of hypercoagulation contributed to comparable skin reactions during radiotherapy...
  4. pmc Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant
    Lisa F Lincz
    Department of Haematology, Calvary Mater Newcastle, Newcastle, NSW, Australia
    Neoplasia 10:1131-7. 2008
    ..This study shows that telomerase activity in melanoma cells is best determined by the absolute expression of full-length hTERT mRNA and indicates a role for the hTERT beta deletion variant in the negative regulation of enzyme activity...
  5. ncbi request reprint Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Misericordiae Hospital, Waratah, Australia
    Blood Coagul Fibrinolysis 18:559-64. 2007
    ....
  6. doi request reprint Circulating microparticles are elevated in carriers of factor V Leiden
    Anoop K Enjeti
    Hunter Haematology Research Group, Calvary Mater Newcastle, Edith Street, Waratah, NSW 2298, Australia
    Thromb Res 126:250-3. 2010
    ..This study was carried out to evaluate if increased numbers or procoagulant potential of circulating MP contribute to the heterogeneity in occurrence of thrombosis in heterozygotes carrying Factor V Leiden (FVL) mutation...
  7. ncbi request reprint Genetic variations in benzene metabolism and susceptibility to multiple myeloma
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Edith Street, Waratah, NSW 2298, Australia
    Leuk Res 31:759-63. 2007
    ..65, 2.49 and 13 times more likely to have MM (P(trend)=0.001)...
  8. ncbi request reprint Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma
    Gough G Au
    The Picornaviral Research Unit, School of Biomedical Sciences, Faculty of Health, The University of Newcastle, Newcastle, NSW, Australia
    Br J Haematol 137:133-41. 2007
    ..Data generated in this study suggests that CVA21 virotherapy may have potential applications as a systemic anti-tumour agent for MM, or in the ex vivo purging of malignant plasma cells prior to autologous stem cell transplantation...
  9. ncbi request reprint Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, NSW, Australia
    Br J Haematol 120:1051-4. 2003
    ..4-fold lower risk of follicular (odds ratio = 0.41, 95% confidence interval: 0.19-0.88, p = 0.02) but not diffuse large B-cell lymphoma. MM patients showed no significant difference in the polymorphisms compared with control subjects...
  10. ncbi request reprint Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele
    Lisa F Lincz
    Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, NSW 2298, Australia
    Int J Cancer 120:1930-4. 2007
    ..This would severely decrease TS expression and may have implications for predicting efficacy and toxicity of therapy with commonly used fluorouracil-based therapy regimes...
  11. doi request reprint Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom
    Geoffrey K Isbister
    Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
    Toxicon 56:75-85. 2010
    ..ETP is a useful assay to investigate mechanisms of other procoagulant venoms and is a robust method of assessing antivenom efficacy...
  12. doi request reprint Microparticles in health and disease
    Anoop K Enjeti
    Department of Haematology level 4, Hunter Haematology Research Group, New Medical Building, Calvary Mater Hospital, Waratah Newcastle, Australia
    Semin Thromb Hemost 34:683-91. 2008
    ....
  13. doi request reprint Detection and measurement of microparticles: an evolving research tool for vascular biology
    Anoop K Enjeti
    Department of Haematology, Calvary Mater Hospital, Waratah Newcastle, Australia
    Semin Thromb Hemost 33:771-9. 2007
    ..Although it has evolved as an important vascular biology research tool, microparticle detection needs further evaluation and refinement before it becomes truly useful as a clinical tool...
  14. doi request reprint Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women
    Melinda Phang
    Nutraceuticals Research Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia
    J Nutr 143:457-63. 2013
    ..With respect to thrombotic disease risk, men are more likely to benefit from supplementation with EPA, whereas women are more responsive to DHA...
  15. ncbi request reprint Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood
    Jennette A Sakoff
    Department of Medical Oncology, Newcastle Mater Misericordiae Hospital, Newcastle, Locked Bag No 7, Hunter Region Mail Center, 2310, NSW, Australia
    Leuk Lymphoma 43:2017-20. 2002
    ..83, P < 0.001). Thus, telomere length in haemopoietic stem cells can be determined from that of whole or fractionated PB in future studies of haematological disorders...
  16. ncbi request reprint Xenobiotic gene polymorphisms and susceptibility to multiple myeloma
    Lisa F Lincz
    Haematologica 89:628-9. 2004
    ....